openPR Logo
Press release

Japan Generics Drug Market Outlook 2020 Report

05-07-2018 08:42 AM CET | Health & Medicine

Press release from: Kuick Resarch

“Japan Generics Drug Market Outlook 2020” Report Highlights:

* Introduction to Japanese Generic Drug Market
* Attractiveness of Japanese Generic Market
* Super Generics in Japan
* Japan Healthcare System & Generic Drugs
* Different Parameters for Generic & Branded Drugs
* Comparison of Generic Drugs in US & Japan
* Japan Generics Drug Market Analysis
* Japan Generics Drug Market Future Prospects

Download Report Sample Weblink:

https://www.kuickresearch.com/report-Japan-Generics-Drug-Market-Outlook-2020.php

For Report Sample Contact: neeraj@kuickresearch.com

Table of Contents

1. Introduction to Japan Generic Drug Market

1.1 Reasons for Growth of Japan Generic Market

1.2 Some Misconceptions Related to Generic Drugs in Japan



2. Attractiveness of Japan Generic Market

2.1 Overview of Japan Pharmaceutical Market

2.2 Features of Japan Generic Drugs Market

2.3 Generic Drug Firms in Japan

2.4 Generic Drugs Import in Japan

2.5 Economic Views about Generic Drugs



3. Scenario of Generic Drugs in Japan

3.1 Scenario for Generic Drug Discount Price in Japan

3.2 Different Categories of Pharmaceutical Patent in Japan

3.3 Promotion of Generic Drugs in Japan



4. Super Generics in Japan

4.1 Introduction to Super Generics

4.2 Advantages of Super Generics

4.3 Disadvantages of Super Generics



5. Different Parameters for Generic & Branded Drugs in Japan

5.1 Patent Protection in Japan

5.2 Effect on Japan Healthcare Spending

5.3 Japan Pharmacological Parameters for Generic Drugs

5.4 Difference in Regulatory Requirements

5.5 Utilization of Branded & Generic Drugs in Japan Market



6. Generic Active Pharmaceutical Ingredients in Japan

6.1 Generic Active Pharmaceutical Ingredient Registration

6.2 Regulation for Foreign Companies in Japan

6.3 Manufacturing Capabilities for Generic API



7. Health in Japan & Utilization of Generic Drugs

7.1 Cancer Incidences in Japan

7.2 Increasing Diabetes Incidences in Japan

7.3 Increasing Cerebrovascular Incidences in Japan

7.4 Cardiovascular Diseases Incidences in Japan

7.5 Disease Caused by Pollution in Japan



8. Healthcare System & Generic Drugs in Japan

8.1 Universal Healthcare Coverage

8.2 Price Rise Control

8.3 Quality Control of Generic Drugs

8.4 Access to Generic Market

8.5 Patents Related Issues to Generic Drugs in Japan

8.6 Factors Restricting Uptake of Generic Drugs in Japan



9. Comparison of Generic Drugs in US & Japan

9.1 Regulatory Framework for Generic Drugs

9.2 Market Penetration of Generic Drugs

9.3 Prices of Generic Drugs

9.4 Perception towards Generic Drugs



10. Japan Generic Drugs Market Analysis



11. Japan Generic Market Favorable Factors

11.1 Ageing Population

11.2 Generic Drugs Regulations

11.3 High Technological Capabilities

11.4 Increasing Disease Incidences



12. Japan Generics Market Commercialization Challenges

12.1 Japan Regulatory Environment

12.2 Attitude towards Generic Drugs

12.3 Lower uptake of Generic Drugs

12.4 Conflicting Patent Laws



13. Japan Generic Drugs Market Future Prospects



14. Competitive Landscape

14.1 Actavis

14.2 Eisai

14.3 Fuji Pharma

14.4 GlaxoSmithKline

14.5 Hospira

14.6 Meiji Seika Pharma

14.7 Nichi-Iko Pharmaceutical

14.8 Nipro Pharma

14.9 Pfizer

14.10 Sawai Pharmaceuticals

14.11 Takeda Pharmaceutical

14.12 Towa Pharmaceutical

Figure 1-1: Reasons for Growth of Japan Generic Market

Figure 1-2: Some Steps taken by Japan Regulators to Decrease Drug Prices

Figure 1-3: Some Misconceptions Related to Generic Drugs in Japan

Figure 2-1: Some Considerations while Approaching Japan Generic Market

Figure 3-1: Discount Determination of Generic Drugs in Japan

Figure 3-2: Type of Drug Price Survey in Japan

Figure 4-1: Advantages of Super Generics

Figure 4-2: Disadvantages of Super Generics

Figure 5-1: Economic Benefits of opting Generic Drugs

Figure 5-2: Regulatory Requirement for Generic Drugs in Japan

Figure 5-3: Utilization of Branded and Generic Drugs in Japan Market

Figure 6-1: Requirements for Registration of API

Figure 6-2: Regulation for Foreign Companies in Japan

Figure 6-3: Japan - Manufacturing Capabilities for Generic API

Figure 7-1: Aim of Basic Plan to Promote Cancer Control Programs

Figure 7-2: Estimated Numbers of Cancer Cases in Japan, 2015

Figure 8-1: Position of Generics in Japan Healthcare System

Figure 8-2: Patents Related Issues to Generic Drugs in Japan

Figure 10-1: Japan - Generics Drug Market (US$ & Yen), 2014-2016

Figure 10-2: Japan - Generics Drug Share in Pharmaceutical Market (%), 2014

Figure 11-1: Japan - Generic Drugs Market Drivers

Figure 12-1: Japan - Generics Market Commercialization Challenges

Figure 13-1: Japan - Generics Drug Market (US$ & Yen), 2017-2020

Figure 13-2: Japan - Generics Drug Share of Prescription Drug (%), 2018

Figure 13-3: Japan - Generics Drug Share of Prescription Drug (%), 2020

Figure 13-4: Japan - Generics Drug Share in Pharmaceutical Market (%), 2020



Table 1-1: Some Important Features of Japan

Table 3-1: Listing Period for Various Drugs in Japan

Table 5-1: Difference between Branded and Generic Drugs in Japan

Table 5-2: Regulatory Requirements for Different Drugs in Japan

Table 7-1: Estimated Numbers of Different Cancer Affecting Japan Population, 2015

Table 7-2: Estimated Numbers of Males Affected by Different Type of Cancer in Japan, 2015

Table 7-3: Estimated Numbers of Females Affected by Different Type of Cancer in Japan, 2015

Table 7-4: Issues related with Cerebrovascular Diseases

Table 7-5: Some Important Diseases caused by Pollutants in Japan

Table 9-1: Difference in Regulatory Framework between Japan & US

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Japan Generics Drug Market Outlook 2020 Report here

News-ID: 1040937 • Views: 470

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases


More Releases for Japan

Japan Agriculture Market, Japan Agriculture Industry, Japan Agriculture Livestoc …
The agriculture sector is a very significant sector in Japan. Agriculture sector exists in every part of country, but is especially essential on the northern island of Hokkaido that accounts for approximately 10% of national production. Modern methods such as commercial fertilizers, hybrid seeds, insecticides, and machinery, have been used so efficiently in farming. Japan is the second major agricultural product importer in the world (after the U.S.). Almost all
Car Navigation ECU Market 2019: Top Key Players are AW Software (Japan), Contine …
Car Navigation ECU Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13844912 Global Car Navigation ECU market 2019 research provides a basic overview of the industry
Global Car Navigation ECU Market Outlook to 2023 – AW Software (Japan), Contin …
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it. Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register a
Global Car Navigation Parts Market Research Report 2019-2025  | Global Key Play …
This research report titled “Global Car Navigation Parts Market” Insights, Forecast to 2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Car Navigation Parts Market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in
Polyphenylene Sulfide (PPS) Global Market 2018 Top Key Players – Celanese (USA …
Global Polyphenylene Sulfide (PPS) Market WiseGuyRerports.com Presents “Global Polyphenylene Sulfide (PPS) Market Outlook 2016-2021” New Document to its Studies Database. The Report Contain 132 Pages With Detailed Analysis. Description Polyphenylene sulfide (PPS) is an organic polymer consisting of aromatic rings linked with sulfides. Synthetic fiber and textiles derived from this polymer are known to resist chemical and thermal attack. PPS is used to make filter fabric for coal boilers, papermaking felts, electrical insulation,
Lawn Mower 2017 Global Market Key Players –Makita(Japan), RYOBI(Japan), Hitach …
Lawn Mower Market 2017 The global Lawn Mower market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies